Daryl Nnani, PharmD, BCTXP retweeted
Congratulations to @PharmDaryl for being named one of the inaugural @ISHLT Fellows. Well deserved! #ISHLT2026
Congratulations to the inaugural Fellow of ISHLT class! 🎉 These 67 members embody the very best of this global, multidisciplinary society. View the full list at 🔗 bit.ly/4bVhUzc
Hope you can join us in Toronto!!
Attend the #ISHLTAcademy in Infectious Disease/Pharmacy: From Pathogens to Pharmacokinetics - Optimizing Outcomes in Thoracic Transplant in Toronto. 🦠💊
📅 Tuesday, 21 April
➡️ Explore the program + register: 🔗 bit.ly/4ucpRXG
#InfectiousDiseases #PharmacyTx #ThoracicTx #transplantation #ISHLT2026
40
Attend the #ISHLTAcademy in Infectious Disease/Pharmacy: From Pathogens to Pharmacokinetics - Optimizing Outcomes in Thoracic Transplant in Toronto. 🦠💊
📅 Tuesday, 21 April
➡️ Explore the program + register: 🔗 bit.ly/4ucpRXG
#InfectiousDiseases #PharmacyTx #ThoracicTx #transplantation #ISHLT2026
Daryl Nnani, PharmD, BCTXP retweeted
Our new study in Transpl Infect Dis found that switching TMP/SMX→atovaquone didn’t reduce #hyperkalemia but was linked to ↑infection risk—and it’s been spotlighted in a Wiley editorial! 📰🔬
📰 onlinelibrary.wiley.com/doi/…
📄 onlinelibrary.wiley.com/doi/…
#CardioTwitter #Transplant
Daryl Nnani, PharmD, BCTXP retweeted
Outstanding posters covering 🫀 transplantation, VADs, and novel desensitization in 🫁 transplantation presented by our trainees tonight. #ISHLT2025
Daryl Nnani, PharmD, BCTXP retweeted
The latest on HCV from the Monte Team! @PharmDaryl @EnklajdM @LDangeloMD @TheVADNP @ISHLT @MonteHeart #ISHLT2025
Daryl Nnani, PharmD, BCTXP retweeted
Replying to @PharmDaryl
@PharmDaryl presents an excellent talk on the 2 Ps! Point of Care Testing for INR and PharmD. Also consider lowering inr to 2.0-2.5 for hmIII patients. Time in therapeutic range (TTR) paramount. @ISHLT #ISHLT2024
Daryl Nnani, PharmD, BCTXP retweeted
3⃣ @PharmDaryl presents 3-year outcomes post #HeartTx of desensitized durable #MCS, from first author JC Youn @CedarsSinai.
🫀▶️pubmed.ncbi.nlm.nih.gov/3715… #ISHLTJournalWatch #ISHLTEarlyCareer
Daryl Nnani, PharmD, BCTXP retweeted
📊August's #ISHLTJournalWatch is here, with topics in #TxPharmacy, edited by Victoria Reams, PharmD @UFHealth, and with contributions from @KrystaWalter12, Ashley Postell @MayoClinic, @PharmDaryl, and @thecurly_Rx.
🔖Read Now: ishlt.org/publications-resou…
#ISHLTEarlyCareer #TxPharm
Daryl Nnani, PharmD, BCTXP retweeted
Ending #ISHLT2023 on a high note! Thanks to my team for being nothing short of amazing. Thanks to @VADCoordinator and @ISHLT for this opportunity. See y'all again in Prague for #ISHLT2024.
Daryl Nnani, PharmD, BCTXP retweeted
🚨The world’s first HIV-positive to HIV-positive #hearttransplant has been successfully performed at Montefiore.
Congratulations to Drs. Ulrich Jorde, Omar Saeed, Daniel Goldstein & the heart transplant team @MonteHeart on this history-making achievement.
prn.to/3J4iF93
Daryl Nnani, PharmD, BCTXP retweeted
An incredible overview of immunosuppression for 🫀transplant recipients by the one and only @PharmDaryl at this morning’s #MonteHeart Fellows Conference.
A sneak peek ⬇️
@ISHLT #ISHLT2021
Has anyone noticed an increase in tacrolimus trough levels after initiation of glecaprevir/pibrentasvir in SOT recipients receiving HCV NAT+ organs? Check out our preliminary findings at ATC. ativsoftware.com/appinfo.php…
#ATC2020VIRTUAL




































